Rhythm Pharmaceuticals, Inc.
Cash Flow Statement
| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-41.4M | $-49.3M | $-55.6M | $-47.5M | $-52.9M | $-46.6M | $-49.5M | $-43.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $25.0M | $26.1M | $23.1M | $19.3M | $18.8M | $15.9M | $12.9M | $10.6M |
| Net Cash from Operating Activities | $-3.1M | $-9.2M | $-44.2M | $-25.4M | $-26.6M | $-23.3M | $-40.4M | $-18.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-16.1M | $14.0M | $57.1M | $30.3M | $-246.3M | $54.0M | $24.8M | $21.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-6.2M | $-1.2M | $-5.4M | $-2.9M | $189.3M | $-889.0K | $32.5M | $38.3M |
| Net Change in Cash | $-25.0M | $3.5M | $7.9M | $2.1M | $-83.4M | $29.6M | $17.0M | $41.6M |
| Free Cash Flow | — | — | — | — | — | — | — | — |